Figure 3
From: PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
Algorithm in predicting response to cetuximab according to the EGFR and K-Ras status, and PTEN protein expression.
Figure 3 | British Journal of Cancer
